SCHEMBL565302

SCHEMBL565302

O=C(O)C1CCC(Nc2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.53
AKR1C1 Q04828 1/20 0.53
GAA P10253 5/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.46
GFER P55789 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
GRIK1 P39086 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
GLA P06280 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
EPHX1 P07099 1/20 0.41
EPHX2 P34913 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2371606 0.91 GAA (0.50) AKR1C3AKR1C1GAAMAPTMEN1
SCHEMBL4076981 0.91 GAA (0.50) AKR1C3AKR1C1GAAMAPTMEN1
Hydrochloric Acid SCHEMBL2400192 0.89 GAA (0.49) AKR1C3AKR1C1GAAMAPTMEN1
Hydrochloric Acid SCHEMBL2400195 0.89 GAA (0.49) AKR1C3AKR1C1GAAMAPTMEN1
SCHEMBL12581586 0.84 RAB9A (0.43) AKR1C3AKR1C1GAAMAPTMEN1
SCHEMBL12391596 0.80 EPHX1 (0.47) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL2344279 0.80 EPHX1 (0.47) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL1966247 0.80 EPHX1 (0.47) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL3033542 0.80 RAB9A (0.58) GAAKMT2AALDH1A1RAB9ANPC1
SCHEMBL2371923 0.80 KDM4E (0.54) GAAMAPTMEN1GFERKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
WO-2010077976-A2 PROKINETICIN RECEPTOR ANTAGONISTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR AKR1C3 2196/4885AKR1C1 2182/4885GAA 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.